Oscillating Positive Expiratory Pressure (OPEP) Devices Market is expected to reach US$ 179.34 Million by 2028

Mouthpiece PEP Segment to Lead Oscillating Positive Expiratory Pressure (OPEP) Devices Market during 2021–2028

According to our latest study on “Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 – COVID-19 Impact Analysis – by Product, Indication, Distribution Channel, and Geography,” the market is expected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The key factors driving the market growth include the prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and advancements in medical technologies.  

Based on product, the oscillating positive expiratory pressure (OPEP) devices market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices held the largest share of the market. The market for this segment is expected to witness the highest CAGR during the forecast period. Mouthpiece PEP helps remove mucus from the lungs. It can also prevent lung collapse or open up areas that have collapsed. One of the key factors driving the market for this segment is the growing elderly population, accompanied by higher rates of chronic illnesses such as chronic obstructive pulmonary disease (COPD) and asthma.

Impact of COVID-19 Pandemic on Oscillating Positive Expiratory Pressure (OPEP) Devices Market

COVID-19 has placed a tremendous strain on healthcare systems globally. According to World Health Organization (WHO), the demand for diagnostic and therapeutic devices increased dramatically in hospitals with the chaotic situation erupted in the healthcare sector. Many health authorities shifted their focus on pandemic-related care in 2020. They postponed elective surgeries, suspended outpatient clinics, and triaged employees involved in urgent care to lower the disease transmission rate at hospitals. However, treating chronic obstructive pulmonary disease (COPD) became critical as these patients are at a greater risk of more adverse outcomes. Positive expiratory pressure (PEP) devices are used as a self-care product by COPD and Covid 19 patients; this device can avoid pneumonia in leukemia patients, probably by reducing evident lung infiltrates via alveolar inflating and secretion relaxation. It can enhance airway clearance and boost functional residual capacity. PEP consumption has been linked to improved gas exchange and reduced atelectasis. Thus, these factors have shown steady growth to the oscillating positive expiratory pressure (OPEP) devices market.

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio;  D•R BURTON HEALTHCARE;  Medica Holdings, LLC;  CEGLA Medizintechnik GmbH & Co. KG;  Able Healthcare; Trudell Medical International; and Mercury Medica are among the leading companies operating in the oscillating positive expiratory pressure (OPEP) devices market.

Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Region, 2021 (%)

---

Oscillating Positive Expiratory Pressure Devices Market Global Report 2028

Download Free Sample

---

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Mouthpiece PEP Devices, Face Mask PEP Devices, and Bottle PEP Devices), Indication [Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others], and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)

Based on product, the oscillating positive expiratory pressure (OPEP) devices market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. Based on indication, the market is segmented into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. The oscillating positive expiratory pressure (OPEP) devices market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By geography, the oscillating positive expiratory pressure (OPEP) devices market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).